Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: A prospective long-term study

European Journal of Paediatric Neurology

Volumn 10, Issue 5-6, 2006, Pages 237-240

  Attilakos, Achilleas ^a   Voudris, Konstantinos A ^b   Garoufi, Anastasia ^a   Mastroyianni, Sotiria ^b   Dimou, Stamatia ^b   Prassouli, Alexia ^a   Katsarou, Eustathia ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

Author keywords

Epileptic children; Liver tests; Serum uric acid; Sodium valproate

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; URIC ACID; VALPROIC ACID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EPILEPSY; FEMALE; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; LIVER FUNCTION TEST; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; URIC ACID BLOOD LEVEL;

ADOLESCENT; ANTICONVULSANTS; CHILD; DEPENDENT AMBULATION; EPILEPSY; FEMALE; HUMANS; LIVER; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; TIME FACTORS; TRANSAMINASES; URIC ACID; VALPROIC ACID;

EID: 33751325658     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2006.09.002     Document Type: Article

References (14)

1. Krause K.H., Berlit P., Schmidt-Gayk H., and Schellenberg B. Antiepileptic drugs reduce serum uric acid. Epilepsy Res 1 (1987) 306-307
2. Beghi E., Bizzi A., Codegoni A.M., Trevisan D., and Torri W. Valproate, carnitine metabolism, and biochemical indicators of liver function. Collaborative Group for the Study of Epilepsy. Epilepsia 31 (1990) 346-352
3. Ring H.A., Heller A.J., Marshall W.J., Johnson A.L., and Reynolds E.H. Plasma uric acid in patients receiving anticonvulsant monotherapy. Epilepsy Res 8 (1991) 241-244
4. Fichsel G., Fichsel H., and Liappis N. Serum uric acid concentration and anticonvulsant therapy in childhood. Klin Padiatr 205 (1993) 429-431
5. Altunbasak S., Yildizas D., Anarat A., and Burgut H.R. Renal tubular dysfunction in epileptic children on valproic acid therapy. Pediatr Nephrol 16 (2001) 256-259
6. Yoshikawa H., Yamazaki S., Watanabe T., and Abe T. Hypouricemia in severely disabled children: influence of valproic acid and bed-ridden state. Brain Dev 25 (2003) 186-190
7. Hamed S.A., Abdellah M.M., and El-Melegy N. Blood levels of trace elements, electrolytes, and oxidative stress/antioxidant systems in epileptic patients. J Pharmacol Sci 96 (2004) 465-473
8. Pylvanen V., Pakarinen A., Knip M., and Isojarvi J. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy. Epilepsy Behav 8 (2006) 643-648
9. Baker J.F., Krishnan E., Chen L., and Schumacher H.R. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?. Am J Med 118 (2005) 816-826
10. Hamed S.A., and Nabeshima T. The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins. J Pharmacol Sci 98 (2005) 340-353
11. Alper Jr. A.B., Chen W., Yau L., et al. Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension 45 (2005) 34-38
12. Yeun J.Y., and Hasbargen J.A. Renal hypouricemia: prevention of exercise-induced acute renal failure and a review of the literature. Am J Kidney Dis 25 (1995) 937-946
13. Ames B.N., Cathcart R., Schwiers E., and Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78 (1981) 6858-6862
14. Watanabe T., Yoshikawa H., Yamazaki S., Abe Y., and Abe T. Secondary renal Fanconi syndrome caused by valproate therapy. Pediatr Nephrol 20 (2005) 814-817